We carried out a genome-wide association study of schizophrenia (479 cases, 2,937 controls) and tested loci with P < 10−5 in up to 16,726 additional subjects. Of 12 loci followed up, 3 had strong independent support (P < 5 × 10−4), and the overall pattern of replication was unlikely to occur by chance (P = 9 × 10−8). Meta-analysis provided strongest evidence for association around ZNF804A (P = 1.61 × 10−7) and this strengthened when the affected phenotype included bipolar disorder (P = 9.96 × 10−9).
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Cardno, A.G. & Gottesman, I.I. Am. J. Med. Genet. 97, 12–17 (2000).
Risch, N. Am. J. Hum. Genet. 46, 222–228 (1990).
Ross, C.A. et al. Neuron 52, 139–153 (2006).
The Wellcome Trust Case Control Consortium. Nature 447, 661–678 (2007).
Rioux, J.D. et al. Nat. Genet. 39, 596–604 (2007).
Zeggini, E. et al. Science 316, 1336–1341 (2007).
Frayling, T.M. et al. Science 316, 889–894 (2007).
Devlin, B. & Roeder, K. Biometrics 55, 997–1004 (1999).
Craddock, N. et al. J. Med. Genet. 42, 193–204 (2005).
Marchini, J. et al. Nat. Genet. 39, 906–913 (2007).
The UK research was supported by grants from the MRC and the Wellcome Trust. We are grateful to the Wellcome Trust Case Control Consortium for access to control genotypes (and to the individuals acknowledged in that respect in ref. 4) and their contribution to the genome-wide study, and to the Welsh e-Science Centre at Cardiff University for access to computing resources for some of this work. In Dublin, the research was supported by Science Foundation Ireland, the Health Research Board (Ireland) and the Wellcome Trust. We are grateful to J. Waddington for sample recruitment. Irish controls were supplied by J. McPartlin and the Trinity College Biobank. In Bonn and Mannheim, the work was supported by the National Genomic Network of the 'Bundesministerium für Bildung und Forschung' (BMBF) and the Alfried Krupp von Bohlen und Halbach-Stiftung. We also thank the Department of Psychiatry, LMU Munich for clinical characterization of the Munich subjects and the processing of the samples. Recruitment in Munich was partially supported by GlaxoSmithKline. The Ashkenazi samples are part of the Hebrew University Genetic Resource.
About this article
Cite this article
O'Donovan, M., Craddock, N., Norton, N. et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 40, 1053–1055 (2008). https://doi.org/10.1038/ng.201
Molecular Psychiatry (2021)
Methylome-wide association study of first-episode schizophrenia reveals a hypermethylated CpG site in the promoter region of the TNIK susceptibility gene
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021)
Convergent genomic and pharmacological evidence of PI3K/GSK3 signaling alterations in neurons from schizophrenia patients
Ciliary neuropeptidergic signaling dynamically regulates excitatory synapses in postnatal neocortical pyramidal neurons
Schizophrenia risk ZNF804A interacts with its associated proteins to modulate dendritic morphology and synaptic development
Molecular Brain (2021)